Summary
Thyroglobulin (Tg) levels in serum of patients with diffuse goiter, “cold” nodules and autonomous adenomas were determined before and during TSH-suppressive therapy with thyroid hormones and antithyroid therapy with carbimazole, respectively.
In normal controls, Tg was found to be 14.5 ng/ml (median), with a range from <10−34 ng/ml (n=27). Tg-levels were significantly elevated in untreated diffuse goiter (median 48 ng/ml, range <10−193 ng/ml,n=68,p≦0.001), as well as in goiters with solid cold nodules (median 72.5 ng/ml, range 14−1,183 ng/ml,n=32,p≦0.001). In these cuthyroid disorders there was no difference in basal or stimulated TSH after TRH. The Tg-levels were unsuppressible in most patients with solid “cold” nodules (median 68.5 ng/ml, range ≦10−569,n=13) and in 25% of the patients with diffuse goiter during effective suppression of TSH with thyroid hormone therapy.
In autonomous adenomas, Tg-levels were also significantly elevated, irrespective of anti-thyroid treatment.
From these data we conclude:
-
1.
The Tg-release is independent from the TSH-stimulation of the thyroid gland in “cold” nodules and autonomous adenomas.
-
2.
Palpatory and scintigraphically defined diffuse goiters are heterogeneous, concerning the Tg-suppressibility in thyroid hormone treatment. This indicates TSH-independent Tg-release and corresponding to solid nodules may indicate autonomously functioning thyroid tissue or leakage of Tg from necrotic follicles, undetectable with conventional diagnostic procedures in vivo.
-
3.
Tg-release seems to be independent from the release of thyroid hormones.
The possible diagnostic vlaue to the Tg-determination in euthyroid diffuse goiters during TSH-suppressive therapy may be the indication for partially autonomous or necrotic thyroid tissue.
Similar content being viewed by others
References
Bernutz C, Gärtner R, Kewenig M, Horn K (1982) A sandwich enzyme immunoassay (EIA) for the determination of thyroglobulin antibodies (TgAb) in human serum. Acta Endocrinol [Suppl 246]: 71–72
Black EG, Gimlette TMD, Maisey MN, Cassoni A, Harmer CL, Oates GD (1981) Serum thyroglobulin in thyroid cancer. Lancet II:443
Botsch H, Schulz E, Lochner B (1979) Serum-Thyreoglobulinbestimmung zur Verlaufskontrolle bei Schilddrüsenkarzinom-Patienten. Dtsch Med Wochenschr 104:1072
Erhardt F, Marschner I, Pickardt CR, Scriba PC (1973) Verbesserung und Qualitätskontrolle der radioimmunologischen Thyrotropin-Bestimmung. Z Klin Chem Klin Biochem II:381
Feldt-Rasmussen U, Beck K, Date J (1979) Serum thyroglobulin in patients with toxic and non-toxic goiter compared to sex- and age-matched control subjects. Acta Endocrinol 91:264–270
Gärtner R, Horn K, Pickardt CR (1980) Improvement of the diagnostic validity of the thyroglobulin radioimmunoassay. Acta Endocrinol [Suppl 243]:30–31
Gärtner R, Kewenig M, Horn K, Scriba PC (1980) A new principle of thyroxine (T4) and triiodothyronine (T3) radioimmunoassay in unextracted serum using antisera with binding optima at extreme pH-ranges. J Clin Chem Clin Biochem 18:571–577
Gärtner R, Kubiczek Th, Horn K, Pickardt CR (1982) “Autonomous” thyroglobulin release in patients with “cold” nodules in endemic goiter and with autonomous adenoma. Acta Endocrinol [Suppl 246]:75–76
Gerfo Lo P, Colacchio T, Colacchio D, Feind C (1979) Thyroglobulin in benign and malignant thyroid disease. JAMA 241:923
Habermann J, Heinze HG, Horn K, Kantlehner R, Marschner I, Neumann J, Scriba PC (1975) Alimentärer Jodmangel in der Bundesrepublik Deutschland. Dtsch Med Wochenschr 100:1937
Herle Van AJ, Uller RP, Matthews NJ, Brown J (1973) Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52:1320–1327
Herle Van AJ, Klamdorf H, Uller RP (1975a) A radioimmunoassay for serum and thyroglobulin: Physiologic and pharmacological studies. J Clin Invest 56:1073–1081
Herle Van AJ, Uller RP (1975b) Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 56:272–277
Herle Van AJ, Chopra IJ, Hershman JM, Hornsbrook RW (1976) Serum thyroglobulin in inhabitants of an endemic goiter region of New Guinca. J Clin Endocrinal Metab 43:512–516
Herle Van AJ, Vassart G, Dumont JE (1979a) Control of thyroglobulin synthesis and secretion (first of two parts). N Engl J Med 301:239–249
Herle Van AJ, Vassart G, Dumont JE (1979b) Control of thyroglobulin synthesis and secretion (second of two parts). N Engl J Med 301:307–314
Horn K, Kubiczek T, Pickardt CR, Scriba PC (1977) Thyroxin-bindendes Globulin (TBG): Präparation, radioimmunologische Bestimmung und klinisch-diagnostische Bedeutung. Klin Wochenschr 55:881–894
Hüfner M, Pollmann H, Grüssendorf M, Schenk M (1980) Die Bedeutung der Thyreoglobulinbestimmung im Serum bei der Nachsorge von Patienten mit differenziertem Schilddrüsenkarzinom. Schweiz Med Wochenschr 5:159–162
Ingrisch H, Heinze HG, Wöhler ZJ, Horn K, Pfeifer KJ, Scriba PC (1974) Absolute Jodaufnahme autonomer Adenome der Schilddrüse vor und nach exogener TSH-Stimulation. DMW 99:1677–1682
Jänsch A, Heinze HG, Hast B (1981) Serum-Thyreoglobulin (S-hTG): Ein Tumormarker bei Patienten mit differenziertem Schilddrüsenkarzinom. Strahlentherapie 157:381
Leisner B, Igl W, Scriba PC (1980) Fortschritte in der Diagnostik der autonomen Schilddrüsenadenome. Act Endocrin 1:91–101
Pacini F, Pinchera A, Giani C, Grasso L, Doveri F, Baschieri L (1980) Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J Endocrinol Invest 3:283–292
Pezzino V, Cozzani P, Filetti S, Galibiati A, Lisi E, Squatuto S, Vigneri R (1977) A radioimmunoassay for human thyroglobulin: methodology and clinical application. Eur J of Clin Invest 7:503–508
Pezzino V, Vigneri R, Squatuto S (1978) Increased serum thyroglobulin levels in patients with nontoxic goiter. J Clin Endocrinol Metab 46:653–657
Pickardt CR, Leisner B, Igl W, Scriba PC (1981) Therapie der blanden Struma, Aussichten und differenzierte Indikation. Verh Deutschen Ges Inn Med 87:410–418
Ramelli F, Studer H, Bruggisser D, Ingold H (1982) The site of leakage of intrafollicular thyroglobulin into the bloodstream in simple goiter. The Second Asia and Oceania Thyroid Association Meeting, August 1982, Tokyo
Rentsch HP, Studer H, Freudiger B, Siebenhüner L (1981) Topographical heterogeneity of basal and thyrotropin-stimulated adenosine 3′, 5′-monophosphate in human nodular goiter. J Clin Endocrinol Metab 53:514–521
Schlumberger M, Fragu P, Parmentier C, Tubiana M (1981) Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue. Acta Endocrinol 98:215–221
Schneider AB, Fervos R (1978) Radioimmunoassay of human thyroglobulin: effect of anti-thyroglobulin autoantibodies. J Clin Endocrinol Metab 47:126–137
Schlossber AH, Jacobsen JC, Ibbertson HK (1979) Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin Endocrinol 10:17–27
Studer H, Hunziker HR, Ruchti C (1978) Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters. Am J Med 65:227–234
Studer H, Forster R, Conti A, Kohler H, Hacberli A, Engler H (1978) Transformation of normal follicles into thyrotropin-refractory “cold” follicles in the aging mouse thyroid gladn. Endocrinology 102:1576–1586
Studer H, Ramelli F (1982) Simple goiter and its variants: euthyroid and hyperthyroid multinodular goiters. Endocrine Rev 3:40–61
Torrigiani C, Doniach D, Roitt JM (1969) Serum thyroglobulin levels in healthy subjects and in patients with thyroid disease. J Clin Endocrinol Metab 29:305–314
Unger J, Heuverswyn B van, Decorter C, Cantraine F, Mockel J, Herle A van (1980) Thyroglobulin and thyroid hormone release after intravenous administration of bovine thyrotropin in man. J Clin Endocrinol Metab 51:590–594
Author information
Authors and Affiliations
Additional information
Supported by Deutsche Forschungsgesellschaft (DFG), Ga272/1-1
Rights and permissions
About this article
Cite this article
Gärtner, R., Hainzinger, A., Horn, K. et al. Evidence for autonomous thyroglobulin release from euthyroid and hyperthyroid nodular goiter — thyroglobulin, a possible helpful parameter in diagnosis of non-malignant thyroid disorders. Klin Wochenschr 61, 737–741 (1983). https://doi.org/10.1007/BF01497400
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01497400